| · Personal control
· Cholesterol testing
· Charitable donations
· Returned medicines
· Dispensing
· The profession
· The Society
· The Charter
· Retention fee
Letters to the Editor
|
Returned medicines
Is there evidence for the Society’s policy?
From Dr G. W. J. Olivier, MRPharmS
We live increasingly in an evidence-based practice profession. In response
to the Broad spectrum article (PJ, 18 September, p378) could I ask for
the evidence that demonstrates that once medicines have been stored in
a domestic environment their quality is compromised? Is the policy of
the Royal Pharmaceutical Society on reissue of medicines based on hypothesis
only or is there published scientific evidence that the quality of blister-packed,
clearly identified, batch-numbered and expiry-dated products stored for
a short time in a patient’s home is compromised?
G. W. J. Olivier
Senior Lecturer in Pharmaceutical Sciences
University of Brighton
| |
SUE KILBY, head of practice, Royal Pharmaceutical Society, states:
There is published evidence to show that inappropriate storage in a
person’s home does affect medicines. Carbamazepine, for example,
could lose one third of its effectiveness if it is stored in humid
conditions (such as exist in most bathrooms). It is for this reason
that the Society's
policy is not to reissue medicine returned to a pharmacy to another
patient.
In many hospitals the policy now is on admission to continue to use
patients’ own
medicines providing they are checked by someone who is properly trained. If
the person checking the medicines is unhappy about their condition for any
reason then they should be discarded and, if required, a new supply issued
for the patient.
Reference
1. Moisture hardens carbamazepine tablets, FDA finds. American Journal of Hospital Pharmacy 1990;47:958. |
|